IrisMed
PrivateLast Round
Seed
Oct 24, 2024
Total Funding Raised
$370,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
IrisMed operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in October 2024.
IrisMed is a health-tech company that provides an AI-powered platform for optometry practices to automate insurance verification, optical quoting, billing, and patient recall.
Sector
Healthcare & Life Sciences
Verticals
Revenue Cycle, Vertical SaaS, Medical AI, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IrisMed Comparables
Compare IrisMed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Toothy AI | 87% | |
| SpexBot | 83% | |
| RapidClaims | 76% |
For institutional investors. Book with your work email.
IrisMed Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
IrisMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Baker Bridge Capital | Seed |
| Techstars | Seed, Accelerator |
| Atlas SGR | Seed |
| Antler | Seed, Accelerator |
| Noemis Ventures | Seed, Accelerator |
| Banyan Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 126% MoM, reaching 2.7K.
- Oct 24, 2024
$250K raised from Atlas SGR, Techstars, and Antler.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- integrates_withAug 13, 2026
IrisMed, Inc. integrates directly with VSP Vision Care Inc. to facilitate smoother claim processing, complemented by automated ERA posting and real-time eligibility verification.
For institutional investors. Book with your work email.
IrisMed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about IrisMed's valuation, stock price, and market status.
Is IrisMed a public or private company?
IrisMed is a private company.
What is the current stock price of IrisMed?
IrisMed is a private company, so its shares have no public market price. Caplight tracks IrisMed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is IrisMed worth (valuation)?
Valuation information for IrisMed is not publicly available.
Can I buy IrisMed stock?
IrisMed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was IrisMed's last funding round?
IrisMed's most recent funding round was Seed on October 24, 2024.
Who are the main investors in IrisMed?
Key investors in IrisMed include Baker Bridge Capital, Techstars, Atlas SGR, Antler, Noemis Ventures.
Will IrisMed IPO soon?
No public IPO plans have been announced for IrisMed.
How can I track IrisMed secondary market activity?
Caplight tracks bids, offers, and trades in IrisMed's shares on secondary markets.